Cargando…
Evaluation of a practice team-supported exposure training for patients with panic disorder with or without agoraphobia in primary care - study protocol of a cluster randomised controlled superiority trial
BACKGROUND: Panic disorder and agoraphobia are debilitating and frequently comorbid anxiety disorders. A large number of patients with these conditions are treated by general practitioners in primary care. Cognitive behavioural exposure exercises have been shown to be effective in reducing anxiety s...
Autores principales: | Gensichen, Jochen, Hiller, Thomas S, Breitbart, Jörg, Teismann, Tobias, Brettschneider, Christian, Schumacher, Ulrike, Piwtorak, Alexander, König, Hans-Helmut, Hoyer, Heike, Schneider, Nico, Schelle, Mercedes, Blank, Wolfgang, Thiel, Paul, Wensing, Michel, Margraf, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983856/ https://www.ncbi.nlm.nih.gov/pubmed/24708672 http://dx.doi.org/10.1186/1745-6215-15-112 |
Ejemplares similares
-
Cost-effectiveness of Practice Team-Supported Exposure Training for Panic Disorder and Agoraphobia in Primary Care: a Cluster-Randomized Trial
por: Brettschneider, Christian, et al.
Publicado: (2020) -
Suicidal ideation in primary care patients suffering from panic disorder with or without agoraphobia
por: Teismann, Tobias, et al.
Publicado: (2018) -
Symptom trajectories in patients with panic disorder in a primary care intervention: Results from a randomized controlled trial (PARADISE)
por: Lukaschek, Karoline, et al.
Publicado: (2019) -
The allocation of resources in the care for patients with panic disorder in Germany: an excess cost analysis informing policy and science
por: Brettschneider, Christian, et al.
Publicado: (2019) -
Patient characteristics and changes in anxiety symptoms in patients with panic disorder: Post-hoc analysis of the PARADIES cluster randomised trial
por: Dreischulte, Tobias, et al.
Publicado: (2022)